Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.

Fertility and sterility - 1 Jun 2010

Xita Nectaria, Lazaros Leandros, Georgiou Ioannis, Tsatsoulis Agathocles

Abstract excerpt

OBJECTIVE: To evaluate the possible contribution of the (TTTA)n polymorphism of aromatase gene (CYP19) to the hyperandrogenic phenotype of polycystic ovary syndrome (PCOS). DESIGN: Case-control study. SETTING: Endocrine outpatients' clinic of a tertiary university hospital. PATIENT(S): One hundred eighty women with PCOS and 160 healthy controls of reproductive age. INTERVENTION(S): Blood sampling for genotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aromatase
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genetic Markers

Share to Polycystic Ovary Syndrome

Share to Polymorphism, Genetic

Share to Young Adult

Source

Identifiers

PMID: 19324338
DOI: 10.1016/j.fertnstert.2009.01.147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.PMID 19324338Read ↗

The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population.Semantic proximity Read ↗

CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome.Semantic proximity Read ↗

The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.Semantic proximity Read ↗

The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women.Semantic proximity Read ↗

The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndromeSemantic proximity Read ↗

Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.Semantic proximity Read ↗

[(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome].Semantic proximity Read ↗

Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.Semantic proximity Read ↗

Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels.Semantic proximity Read ↗

A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro.Semantic proximity Read ↗

The association of aromatase (CYP19) gene variants with sperm concentration and motility.Semantic proximity Read ↗

Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.